Rankings
▼
Calendar
PTCT Q3 2022 Earnings — PTC Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
PTCT
PTC Therapeutics, Inc.
$6B
Q3 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$217M
+56.5% YoY
Gross Profit
$203M
93.5% margin
Operating Income
-$73M
-33.8% margin
Net Income
-$109M
-50.3% margin
EPS (Diluted)
$-1.53
QoQ Revenue Growth
+31.2%
Cash Flow
Operating Cash Flow
-$38M
Free Cash Flow
-$64M
Stock-Based Comp.
$29M
Balance Sheet
Total Assets
$1.6B
Total Liabilities
$1.8B
Stockholders' Equity
-$227M
Cash & Equivalents
$104M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$217M
$139M
+56.5%
Gross Profit
$203M
$132M
+53.6%
Operating Income
-$73M
-$93M
+21.0%
Net Income
-$109M
-$134M
+18.2%
Geographic Segments
Non-US
$77M
58%
United States
$55M
42%
← FY 2022
All Quarters
Q4 2022 →